Innovative treatment for extrapulmonary benefits in COPD: effects and mechanisms of supramaximal High-Intensity Training

COPD-HIT aims to explore and enhance extrapulmonary treatments for COPD through high-intensity training, focusing on brain health, muscle quality, and cardiac function via innovative research methods.

Subsidie
€ 1.490.438
2023

Projectdetails

Introduction

Given the substantial negative impact of extrapulmonary manifestations on vital clinical outcomes, including mortality, the need for new effective treatment modalities beyond the lungs has been highlighted as an urgent challenge in the management of chronic obstructive pulmonary disease (COPD), one of the most common and deadliest diseases of the 21st century.

Project Aim

The aim of COPD-HIT is to pave the way for new understanding of the development and treatment of extrapulmonary manifestations in COPD with a focus on brain health, muscle quality, and cardiac function.

Research Objectives

To do this, I will focus on the following research objectives (RO):

  1. RO1: Determine the effect of supramaximal High-Intensity Training (HIT) on the brain, muscle, and heart.
  2. RO2: Determine how exercise training and inflammation impact the trajectories of neurodegeneration.
  3. RO3: Develop a novel in-vitro model to determine signaling pathways following various loading intensities.

Methodology

To reach these objectives, I aim to conduct high-quality multicenter randomized controlled and experimental trials.

Further, I will lead an international research alliance with access to state-of-the-art research infrastructures and enable a unique interdisciplinary approach to fulfill my goals. This includes:

  • Using advanced measurement techniques for muscle, brain, and cardiorespiratory evaluations.
  • Conducting muscle biopsy analyses.
  • Implementing in-vivo & in-vitro strategies.
  • Combining quantitative and qualitative methods.

Conclusion

Taken together, with COPD-HIT, I am in a strong position to perform an international novel project that will determine how to enable extrapulmonary benefits in COPD in a hitherto unprecedented way.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.490.438
Totale projectbegroting€ 1.490.438

Tijdlijn

Startdatum1-7-2023
Einddatum30-6-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UMEA UNIVERSITETpenvoerder

Land(en)

Sweden

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

Understanding the host-environmental interactions across the lifespan determining lung function trajectories and COPD

PredictCOPD aims to identify early-life gene-environment interactions that influence lung health trajectories, with the goal of preventing COPD and associated multimorbidity through targeted interventions.

€ 1.998.319
ERC COG

Dynamic engIneered heart tiSsue to Study intEr-individual susCeptibily and improve Treatment of Heart Failure

DISSECT-HF aims to engineer heart tissue from patient-specific stem cells to uncover common mechanisms of heart failure across different etiologies and improve treatment strategies.

€ 1.998.775
ERC ADG

Regulation of the L-arginine – ADMA – Nitric Oxide (NO) Pathway in the Pulmonary Vascular Response to Hypoxia and its Role for Survival of High-Risk COPD Patients

NO PRESSURE aims to uncover the role of intermittent hypoxaemia in COPD progression and identify high-risk patients through innovative molecular and clinical studies targeting the L-arginine-ADMA-NO pathway.

€ 2.499.927
ERC ADG

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

€ 2.500.000